trending Market Intelligence /marketintelligence/en/news-insights/trending/IN1MNWqY2NKXe7ml_i_fQQ2 content esgSubNav
In This List

Neovasc closes $5M stock offering to fund heart device development

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Neovasc closes $5M stock offering to fund heart device development

Neovasc Inc. closed an underwritten public offering of 11,111,111 common shares, priced at 45 cents each.

The Richmond, British Columbia-based medical-device maker raised $5 million in gross proceeds that will be used to develop and commercialize its heart devices Neovasc Reducer and Tiara.

Funds from the offering will also be used for general corporate and working capital purposes.

H.C. Wainwright & Co. served as the sole book-running manager for the offering.